
DataMEDS AI rose 9.7% from $0.59 to $0.64, behind the S&P 500's +11.2%. Its worst day was Aug 7 (−24.6%), and its low came May 12 at $0.08.
Nov 17, 2025 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-23.00 was reported on $3.0M revenue.
−15.6% · S&P 500 −1.5%
EPS of $-12.50 was reported on $1.7M revenue.
−8.0% · S&P 500 +1.1%
Story events cover the past 12 months · Times ET
DataMEDS AI closed at its lowest level of the year, 86.5% below where the year started.
−14.4% · S&P 500 −0.2%
EPS of $-3.50 was reported on $1.6M revenue.
−23.2% · S&P 500 +1.0%
EPS of $-7.13 was reported on $1.8M revenue.
+0.7% · S&P 500 −0.5%
DataMEDS AI closed at its highest level of the year, 937.4% above where the year started.
+274.7% · S&P 500 −0.4%
EPS of $2.72 was reported on $2.7M revenue.
−14.5% · S&P 500 −0.4%
Where it ended: a close of $0.64 on Nov 16, 2026.
Nothing in the past 12 months.
All MEDS analyst actionsNothing in the past 12 months.
All MEDS dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for MEDS and SPY from Benzinga historical bars. Not investment advice.